{"id":"NCT01657253","sponsor":"Laboratorios Sophia S.A de C.V.","briefTitle":"Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye","officialTitle":"A Randomized, Double-blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11","primaryCompletion":"2015-02","completion":"2015-04","firstPosted":"2012-08-06","resultsPosted":"2017-12-15","lastUpdate":"2017-12-15"},"enrollment":183,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Dry Eye"],"interventions":[{"type":"DRUG","name":"PRO-148","otherNames":["PRO-148 (xanthan gum and sulphate chondroitin)"]},{"type":"DRUG","name":"Systane","otherNames":["polyethyleneglycol 400, propyleneglycol, hydroxypropyl guar"]}],"arms":[{"label":"PRO-148","type":"EXPERIMENTAL"},{"label":"Systane®","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate efficacy and safety of the ophthalmic solution PRO-148 in the ocular surface of patients with mild to moderate dry eye compared with ophthalmic solution Systane®","primaryOutcome":{"measure":"Ocular Surface Disease Index (OSDI©) Questionnaire","timeFrame":"Day 60","effectByArm":[{"arm":"PRO-148","deltaMin":19.3,"sd":7.4},{"arm":"Systane®","deltaMin":19.3,"sd":7.5}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":11},"locations":{"siteCount":1,"countries":["Mexico"]},"refs":{"pmids":["27645318"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":93},"commonTop":["Conjunctivitis","rhinitis","ocular burning sensation","Pruritus","Red eye"]}}